mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
-0.43 |
0.01 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |